With injections, people often experience faster results, especially when addressing issues like detoxification, oxidative stress, skin health, or inflammation management
Public and private payers have been trying to wean patients off to save costs
Challenges: The key challenge for Sanofi is competition from more established and better marketed GLP-1 drugs, particularly those from Novo Nordisk and Eli Lilly
Authors also thank the Slovak Grant Agencies VEGA Project 1/0542/24 and Project APVV 190087
154 BCRP, a half-transporter encoded by ABCG2, functions as a homodimer and mediates the efflux of topotecan, SN-38, mitoxantrone, and several TKIs, such as imatinib and osimertinib